PebblePilot
Well-known member
Groundbreaking Blood Test Could Revolutionize Cancer Diagnostics, Study Finds
A new blood test has shown promising results in identifying cancerous DNA fragments that have broken off from tumors and are circulating in the bloodstream. The test, known as Galleri, has been developed by American pharmaceutical firm Grail and is currently being trialed by the NHS.
The study, which followed 25,000 adults in North America over a year, found that nearly one in 100 tested positive for cancer, with an impressive 62% of these cases later confirmed. The test was able to detect fragments of DNA from more than 50 types of cancer, including three-quarters that do not have any screening program.
The Galleri test works by detecting the presence of cancer-specific DNA fragments in blood samples, which can be used to identify the type and origin of cancer. In nine out of 10 cases, the test correctly identified the origin of the cancer.
While the results are exciting, scientists caution that further research is needed to determine whether the test reduces deaths from cancer. The NHS will soon begin a three-year trial involving 140,000 patients in England, with the aim of extending the test to an additional one million people if successful.
The potential impact of this test cannot be overstated, as many cancers are currently diagnosed at advanced stages when treatment options are limited. Early detection through screening programs can significantly improve treatment outcomes and survival rates.
However, there is also a risk of overdiagnosis, where cancerous tumors are detected that may not have caused harm or will not progress to life-threatening disease. It's essential that further research focuses on determining the benefits and risks of this test in reducing mortality from cancer.
As Dr Nima Nabavizadeh, lead researcher, emphasized, "This data shows us that we can fundamentally change our approach to cancer screening." If successful, the Galleri test could revolutionize the way cancer is diagnosed and treated, offering new hope for patients and their families.
A new blood test has shown promising results in identifying cancerous DNA fragments that have broken off from tumors and are circulating in the bloodstream. The test, known as Galleri, has been developed by American pharmaceutical firm Grail and is currently being trialed by the NHS.
The study, which followed 25,000 adults in North America over a year, found that nearly one in 100 tested positive for cancer, with an impressive 62% of these cases later confirmed. The test was able to detect fragments of DNA from more than 50 types of cancer, including three-quarters that do not have any screening program.
The Galleri test works by detecting the presence of cancer-specific DNA fragments in blood samples, which can be used to identify the type and origin of cancer. In nine out of 10 cases, the test correctly identified the origin of the cancer.
While the results are exciting, scientists caution that further research is needed to determine whether the test reduces deaths from cancer. The NHS will soon begin a three-year trial involving 140,000 patients in England, with the aim of extending the test to an additional one million people if successful.
The potential impact of this test cannot be overstated, as many cancers are currently diagnosed at advanced stages when treatment options are limited. Early detection through screening programs can significantly improve treatment outcomes and survival rates.
However, there is also a risk of overdiagnosis, where cancerous tumors are detected that may not have caused harm or will not progress to life-threatening disease. It's essential that further research focuses on determining the benefits and risks of this test in reducing mortality from cancer.
As Dr Nima Nabavizadeh, lead researcher, emphasized, "This data shows us that we can fundamentally change our approach to cancer screening." If successful, the Galleri test could revolutionize the way cancer is diagnosed and treated, offering new hope for patients and their families.
this is literally amazing news! a blood test that can detect cancer from anywhere in the body? it's like something out of a sci-fi movie 
imagine being able to catch cancer so early you're not even aware you have it, before it spreads. and with all these types of cancer it can detect, the potential impact on mortality rates is huge 
just think about how many lives this could save. and the fact that it's already showing 62% accuracy rate in its trial? game changing 
- nearly one in 100 people testing positive for cancer? that's wild! I mean, it’s not all good news though, they need to figure out the risks of overdiagnosis too. But if it can catch cancers early enough, it could be a game changer 
. My aunt had breast cancer like 5 years ago and she was diagnosed pretty late... this test might have caught it sooner. Not sure about the NHS trial yet but I’m intrigued 
. The fact that this test can detect fragments of DNA from over 50 types of cancer is mind-blowing 
It's like, yeah, let's find ways to make this test better so it can actually help people, not just create more anxiety for everyone involved 
THE IDEA OF BEING ABLE TO DETECT CANCER AT AN EARLY STAGE AND CATCH IT BEFORE IT SPREADS IS TRULY LIFE-CHANGING. I MEAN, THINK ABOUT ALL THE PEOPLE WHO COULD BENEFIT FROM THIS TEST - THE ONES WHO CURRENTLY GET DIAGNOSED WITH ADVANCED CANCER AND HAVE LIMITED TREATMENT OPTIONS.
. We need to make sure this test is safe and effective for everyone. Overdiagnosis is a real concern, and we need to figure out how to balance benefits with risks 
. Still, I'm super optimistic about the potential impact of this test. It could be the key to catching cancer at an early stage and saving lives 
.
Still, the potential benefits are huge, especially for people who wouldn't normally get screened because their cancer type isn't common. Maybe we'll finally see some real progress in cancer research... let's keep our fingers crossed! 
anyway i was thinking about this new test and how amazing it would be to catch cancer earlier...like as early as next year maybe? wouldn't that be something?! 
also can we talk about how much money this could save us in healthcare costs?? like we could use the funds for actual help instead of just testing